Your Shopping Cart Is Empty
| Report Code: A01134 | Pages: 284 | ||
| Tables: 144 | Charts: 34 |
| |
The global cancer vaccines market was valued at $4,188 million in 2019, and is projected to reach $7,303 million by 2027, registering a CAGR of 12.6% from 2020 to 2027.
Cancer vaccines are medicines considered as biological response modifiers. These biological response modifiers work by stimulating the immune system of body to fight against cancer. Preventive cancer vaccines and therapeutic cancer vaccines are two types of cancer vaccines. Preventive cancer vaccines are used in healthy person to prevent cancer. Therapeutic cancer vaccines are used in cancer patients to strengthen their immune response to fight against the disease. Cancer vaccines can be administered intravenously (IV) in children as well as in adults.
Increase in number of cancer patients, rise in geriatric population, surge in patient awareness towards cancer therapy, increase in cancer vaccines usage combined with other therapies, increase in prevalence of human papilloma virus (HPV) infections, and increase in investments and government funding in development of cancer vaccines by manufacturers are the major factors that drive growth of the cancer vaccines market. In addition, technological developments in cancer vaccines, launch of novel cancer vaccines, rise in health care services and expenditure, and rise in adoption rates of preventive and therapeutic vaccines are some other factors that contribute toward growth of the market. Moreover, increase in tobacco consumption and unhealthy dietary habits are leading risk factors for the rise in number of cancer cases, which further drives growth of the cancer vaccines market. However, high cost for developing cancer vaccines and longer time span required for manufacturing a single vaccine are anticipated to restrict the market growth.
COVID-19 Impact on Cancer Vaccines Market
The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. Cancer vaccines manufacturing and distributing companies have been affected by COVID-19 to a limited extent, owing to shutdown in various COVID-19 affected countries and rise in number of healthcare workers falling ill in the wake of the COVID-19 pandemic, leading to short supply.
Cancer Vaccines Market Segmentation
The global cancer vaccines market is segmented on the basis of technology, type, indication, end user, and region. By technology, the market is categorized into dendritic cells (DC) cancer vaccines, recombinant cancer vaccines, antigen/adjuvant cancer vaccines, and viral vector & DNA cancer vaccines. By type, it is bifurcated into preventive cancer vaccines and therapeutic cancer vaccines. By indication, it is classified into cervical cancer, prostate cancer, and others. By end user, it is divided into pediatric and adult. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Segment Review
Presently, on the basis of technology, the recombinant cancer vaccines segment is the major revenue contributor, and is projected to grow significantly during the forecast period. Increase in adoption of recombinant technology, rise in utilization of recombinant vaccines, and surge in number of approved cancer vaccines developed using recombinant technology are the key factors that boost growth of the segment.
Depending on indication, the cervical cancer segment is the major shareholder in the global cancer vaccines market, owing to high prevalence of cervical cancer and increase in number of people suffering from human papilloma virus (HPV) infections. In addition, rise in geriatric population, drug development in the field of cervical cancer, and increase in patient awareness toward cervical cancer drive growth of the segment.
Snapshot of Asia-Pacific Cancer Vaccines Market
Asia-Pacific presents lucrative opportunities for key players operating in the cancer vaccines market, owing to rise in adoption of cancer vaccines, increase in number of cancer patients in emerging economies, development of the R&D sector, rise in healthcare reforms, and technological advancements in cancer vaccines. Moreover, rise in demand for cancer vaccines, surge in funding from government and non-government sectors to develop novel cancer vaccines, rise in number of hospitals & diagnostic centers equipped with advanced medical facilities, and presence of high population base contributes toward growth of the market. Moreover, surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high market share is expected to drive growth of the cancer vaccines market in the region.
The key players profiled in this report include Advaxis Inc., Amgen Inc., Dynavax Technologies Corporation, Generex Biotechnology Corporation, GlaxoSmithKline plc (GSK), Immunocellular Therapeutics, Ltd, Merck & Co., Inc., Sanpower Group Co. Ltd. (Dendereon Corporation), UbiVac, and Vaccinogen, Inc.
Cancer Vaccines Market Report Highlights
| Aspects | Details |
|---|---|
| By TECHNOLOGY |
|
| By TYPES |
|
| By INDICATION |
|
| By END USER |
|
| By Region |
|
| Key Market Players | Merck & Co., Inc., Vaccinogen, Inc., Immunocellular Therapeutics, Ltd, UbiVac, GlaxoSmithKline plc (GSK), Amgen Inc., Advaxis Inc., SANPOWER GROUP CO. LTD. (DENDEREON CORPORATION), Generex Biotechnology Corporation, Dynavax Technologies Corporation |
Loading Table Of Content...
Cancer vaccines are medications that stimulate the immune system of the body to fight against disease. Moreover, it can be administered intravenously in children as well as adults.
Rise in prevalence of cancer, increase in demand for novel cancer vaccine products, rise in adoption rates of preventive and therapeutic vaccines, and rise in investments by government & private organizations for the production of cancer vaccines significantly boost growth of the cancer vaccines market. However, high cost for developing cancer vaccines and longer time required for manufacturing a single vaccine are anticipated to restrict the market growth.
North America is expected to remain dominant during the forecast period, owing to rise in cases of cancer, high unmet demand for cancer vaccines, higher healthcare awareness, presence of well-developed healthcare infrastructure, presence of trained medical professionals, and early detection of the disease, which supports the market growth. In addition, strong reimbursement policies, presence of large number of hospitals & diagnostic centers equipped with advanced healthcare systems, and strong presence of key players supplement growth of the market in the region. In addition, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to key players during the forecast period, owing to rise in number of cancer affected population with rise in demand for cancer vaccines.
A. The total market value of Cancer Vaccines market is $4,187.62 million in 2019.
A. The forcast period for Cancer Vaccines market is 2020 to 2027
A. The market value of Cancer Vaccines market in 2020 is $3,345.07 million.
A. The base year is 2019 in Cancer Vaccines market
A. Top companies such as Merck & Co., Inc., Amgen Inc., GlaxoSmithKline plc, Dynavax Technologies, and Sanpower Group Co., Ltd. (Dendron) held a high market position in 2019. These key players held a high market postion owing to the strong geographical foothold in different regions.
A. Recombinant cancer vaccines segment is the most influencing segment owing to recombinant cancer vaccines are most efficient alternative to traditional vaccines in the prevention of various human diseases, and rise in adaption due to rapid elimination of risk of active infection.
A. The major factor that fuels the growth of the global Cancer Vaccines market includes rise in prevalence of cancer such as breast cancer, prostate cancer, cervical, lung cancer, and others globally, and surge in investments and governmental funding in the development of cancer vaccines by manufacturers, increase in cancer usage combined with other therapies, surge in demand for cancer vaccines, rise in public awareness towards benefits of cancer vaccines, increase in prevalence of human papilloma virus (HPV) infections, and launch of new cancer vaccines.
A. The major factor that fuels the growth of the global Cancer Vaccines market includes rise in prevalence of cancer such as breast cancer, prostate cancer, cervical, lung cancer, and others globally, and surge in investments and governmental funding in the development of cancer vaccines by manufacturers, increase in cancer usage combined with other therapies, surge in demand for cancer vaccines, rise in public awareness towards benefits of cancer vaccines, increase in prevalence of human papilloma virus (HPV) infections, and launch of new cancer vaccines.
A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as China with a CAGR of 17.0%. This is due to rise in adoption of cancer vaccines treatment medication, increase in number of cancer patients, rise in demand for cancer vaccines, improvement in health awareness, development in healthcare infrastructure, and rise in number of hospitals & diagnostic centers equipped with advanced medical facilities
A. Cancer vaccine is a type of immunotherapy that boosts the natural defense of the body by stimulating the immune system to recognize and cure cancerous cells.
A. Cancer vaccine is a type of immunotherapy that boosts the natural defense of the body by stimulating the immune system to recognize and cure cancerous cells.
A. Cancer Vaccines products are used to effectively fight against cancer disease.
A. Cancer Vaccines products are used to effectively fight against cancer disease.
Start reading instantly.
This Report and over 71,229+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report